ADENOCARCINOMA OF THE GASTRIC CARDIA - RECURRENCE AND SURVIVAL AFTER RESECTION

被引:0
作者
BLOMJOUS, JGAM
HOP, WCJ
LANGENHORST, BLAM
TENKATE, FJW
EYKENBOOM, WMH
TILANUS, HW
机构
[1] ERASMUS UNIV,HOSP DIJKZIGT,DEPT SURG,DR MOLENWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS
[2] DR DANIEL DEN HOED CANC CTR,ROTTERDAM,NETHERLANDS
[3] ERASMUS UNIV,DEPT EPIDEMIOL & BIOSTAT,3015 GD ROTTERDAM,NETHERLANDS
[4] ERASMUS UNIV,DEPT PATHOL,3015 GD ROTTERDAM,NETHERLANDS
关键词
CARDIA; ADENOCARCINOMA; RECURRENCE; SURVIVAL; PROGNOSIS;
D O I
10.1002/1097-0142(19920801)70:3<569::AID-CNCR2820700305>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between January 1, 1983, and December 31, 1988, operations were performed on 112 patients with adenocarcinoma of the gastric cardia. Resection of the primary tumor was performed in 93 patients. For these 93 patients, follow-up until July 1, 1989, averaged 24 months, during which time 59 patients died. Positive resection margins carried a greater risk for the development of a local recurrence but did not correlate with survival. The cumulative overall 5-year actuarial recurrence rate was 69%. The cumulative 5-year recurrence rate for metastases was 64% and for locoregional recurrence it was 36%. The overall 5-year survival rate was 24%. Differences in survival were observed between patients with carcinomas of the various subgroups of the 1987 TNM classification system (T1-T2 versus T3-T4, No versus N1-N2, M0 versus M1, Stages I-II versus Stages III-IV, Grades 1-2 versus Grades 3-4). In particular, lymph node status as correlated with histopathologic grade showed remarkable differences in survival: patients with no positive lymph nodes in the resection specimen and a Grade 1 or 2 tumor had a significantly better 5-year survival rate (53%) than the other subgroups (N0/Grades 3-4: 21%; N1-N2/Grades 1-2: 12%; N1-N2/Grades 3-4: 14%).
引用
收藏
页码:569 / 574
页数:6
相关论文
共 26 条
[1]   ADENOCARCINOMA OF THE CARDIA - A 10-YEAR REGIONAL REVIEW [J].
ALLUM, WH ;
ROGINSKI, C ;
FIELDING, JWL ;
JONES, BG ;
ELLIS, DJ ;
WATERHOUSE, JAH ;
BROOKES, VS .
WORLD JOURNAL OF SURGERY, 1986, 10 (03) :462-467
[2]  
ANTONIOLI DA, 1982, CANCER, V50, P775, DOI 10.1002/1097-0142(19820815)50:4<775::AID-CNCR2820500425>3.0.CO
[3]  
2-W
[4]  
CASTRINI G, 1981, J THORAC CARDIOV SUR, V82, P190
[5]  
CURTIS RE, 1985, SEMIN ONCOL, V12, P21
[6]   LIMITED ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE CARDIA - INDICATIONS, TECHNIQUE, AND RESULTS [J].
ELLIS, FH ;
GIBB, SP ;
WATKINS, E .
ANNALS OF SURGERY, 1988, 208 (03) :354-361
[7]  
GIULI R, 1986, SURGERY, V99, P614
[8]  
HENNESSY TPJ, 1987, J THORAC CARDIOV SUR, V94, P64
[9]  
HOLSCHER AH, 1985, DIGEST SURG, V2, P1
[10]  
HUSEMANN B, 1983, MUNCHEN MED WOCHEN, V125, P61